Medical Health Cluster

Variantes Covid

Omicron subvariant BA.2 spreading rapidly in L.A. and across the nation

The percentage of Omicron subvariant BA.2 cases is rising in Los Angeles County, a trend seen elsewhere nationwide as officials sound the alarm about Congress’ failure to provide critical funding for vaccinations, tests and anti-COVID drugs. Officials in L.A. County and nationally have warned about the risk to public health […]

Read More

Once Viewed as a Promising COVID-19 Treatment, Convalescent Plasma Falls Out of Favor

In the pandemic’s initial dark days, physicians and patients and their families were desperate for effective COVID-19 treatments. They didn’t yet have monoclonal antibodies or antiviral pills to lessen the ravages of the disease, so many turned to a therapy more than a century old. At the very least, they […]

Read More

Rare and Preventable: Painful Post-vax Shoulder Problems

Deltoid bursitis and other shoulder conditions that may develop after vaccination injections into the deltoid muscle are painful, but they’re also rare and preventable, according to a new study. Doctors and patients have long been familiar with shoulder problems after intramuscular vaccination into the deltoid, but epidemiologic studies that shed light on the […]

Read More

Health Officials Urge Preparation, Not Panic, for Next COVID Wave

As top U.S. health officials track the latest COVID-19 spike in Europe, they’re encouraging Americans not to panic about another potential wave hitting the country. “Our focus should be on preparation, not on panic,” Vivek Murthy, MD, the U.S. surgeon general, said on  Fox News Sunday. BA.2, the Omicron subvariant, has […]

Read More

Boosted Americans 97 Times Less Likely to Die of COVID Than Unvaccinated

Americans who have received a COVID-19 booster shot are 97 times less likely to die from the coronavirus than those who aren’t vaccinated, according to a new update from the CDC. In addition, fully vaccinated Americans — meaning those with up to two doses, but no booster — are 14 […]

Read More

Moderna Reports Positive COVID-19 Vaccine Response in Kids Down to 6 Months

Moderna on Wednesday released interim results indicating that its mRNA-1273 COVID vaccine produced “robust” neutralizing antibody titers in children aged 6 months to 6 years — levels similar to those seen in adults. Vaccine efficacy against infection was 43.7% in children aged 6 months to 2 years and 37.5% among […]

Read More

Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine

BACKGROUND Active immunization with the BNT162b2 vaccine (Pfizer–BioNTech) has been a critical mitigation tool against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the coronavirus disease 2019 (Covid-19) pandemic. In light of reports of waning protection occurring 6 months after the primary two-dose vaccine series, data are needed on […]

Read More

Mandatory masking in schools reduced COVID-19 cases

SARS-CoV-2, the virus that causes COVID-19, most commonly spreads from person to person through respiratory droplets. These droplets travel through the air when people cough, sneeze, or talk. Studies show that masks reduce the release of droplets when worn over the nose and mouth. While masks can prevent individuals from […]

Read More

The COVID Heart—One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks

An analysis of data from nearly 154 000 US veterans with SARS-CoV-2 infection provides a grim preliminary answer to the question: What are COVID-19’s long-term cardiovascular outcomes? The study, published in Nature Medicine by researchers at the Veterans Affairs (VA) St Louis Health Care System, found that in the year after recovering from the illness’s […]

Read More

Subsidized COVID Testing, Treatments, and Vaccines May End Soon

The federal government this week will begin cutting back on the anti-COVID-19 antibody treatments it ships to states, and doctors will no longer get paid for providing COVID-19 care for the uninsured, as the nation runs out of money to buy crucial tests, treatments, and vaccines needed to keep the […]

Read More